USANA Health Sciences, Inc.
Consumer DefensiveNYSE:USNA · New York Stock Exchange
+$0.04 today
Vol 0.08M · Avg 0.12M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
2.0%
avg 21.7%
ROIC
2.2%
avg 20.1%
ROA
1.4%
avg 15.1%
Analysis
ROIC is currently the strongest return metric at 2.2% versus its period average of 20.1%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Kevin G. Guest | CEO & Executive Chairman | $1.04M | — | 63 | $127,206.00 | 0.69% |
Walter Noot | Chief Operating Officer | $869,066.00 | — | 60 | $75,130.00 | 0.41% |
G. Douglas Hekking | Chief Financial Officer | $842,932.00 | — | 56 | — | — |
Joshua Foukas | Chief Legal Officer, General Counsel & Corporate Secretary | $760,904.00 | — | 50 | $0.00 | <0.01% |
Brent L. Neidig | Chief Commercial Officer | $602,799.00 | — | 42 | $67,447.00 | 0.37% |
David Mulham | Chief Sales Officer | $601,721.00 | — | 66 | $8,387.00 | 0.05% |
John Cuomo | Executive Director of Product Development & Technology | — | — | — | $4,230.00 | 0.02% |
Kathryn Armstrong | Chief Scientific Officer | — | — | 45 | $40,592.00 | 0.22% |
Myron W. Wentz | Founder & Chairman Emeritus | — | — | 85 | $7.41M | 40.13% |
Patrique Richards | Executive Director of Investor Relations & Business Development | — | — | — | — | — |
Peter Benedict | Chief Information Officer | — | — | — | $0.00 | <0.01% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
16
$980,001.99
Net Sentiment
$980,001.99
Net selling
Most Active
FULLER GILBERT A
4 transactions
1–10 of 16
Analysis
Insiders reported 0 buys worth $0.00 and 16 sells worth $980,001.99 over the last 12 months. That adds up to net selling of $980,001.99. FULLER GILBERT A was the most active insider with 4 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +17.2% | -2.0% (13yr)1 analysts |
| Revenue | N/A | N/A | +12.3% | +0.7% (13yr)1 analysts |
| Net Income | N/A | N/A | +12.5% | -4.6% (13yr)1 analysts |
| EBIT | N/A | N/A | +13.0% | -2.6% (13yr)1 analysts |
Analysis
Recent growth has been strongest in EPS at +17.2% over three years. Forward estimates point to Revenue at +0.7% (13yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Westrock Coffee Company, LLC
NASDAQ:WEST
$926.80M
Mama's Creations, Inc.
NASDAQ:MAMA
$606.94M
Dingdong (Cayman) Limited
NYSE:DDL
$521.92M
Calavo Growers, Inc.
CVGW
$466.33M
Vasta Platform Limited
VSTA
$394.00M
Lifeway Foods, Inc.
NASDAQ:LWAY
$383.12M
BrasilAgro - Companhia Brasileira de Propriedades Agrícolas
NYSE:LND
$372.56M
B&G Foods, Inc.
NYSE:BGS
$327.10M
QuantaSing Group Ltd
QSG
$274.08M
BRC Inc.
NYSE:BRCC
$159.13M
Who manages USNA?
USANA Health Sciences, Inc. (USNA) lists 11 active executives. The top listed executive is John Cuomo, Executive Director of Product Development & Technology.
Are USNA insiders buying or selling?
Recent insider activity shows net selling of $2.50M.
Explore More
Continue the stock analysis
Jump to another research area for this company.